Core Insights - OneMedNet Corporation has entered into a data license agreement with a leading U.S.-based company in clinical trial design, enhancing its market expansion strategy and commercial reach in the life sciences industry [1][2][6] - The partnership aims to leverage OneMedNet's proprietary iRWD™ platform, which manages a diverse set of clinical data, to accelerate the development of new medical therapies and technologies [2][6] - OneMedNet's iRWD™ network includes data from over 1,400 healthcare systems and provider sites, providing significant research opportunities for drug, medical device, and imaging/diagnostic AI development [2][6][8] Company Overview - OneMedNet specializes in regulatory-grade Real World Data (RWD), including electronic health records, laboratory results, and medical imaging [1][2] - The company is committed to enhancing patient outcomes and supporting healthcare innovation across various domains, including rare diseases, oncology, and cardiology [8] - The iRWD™ platform is designed to securely de-identify, search, and curate clinical data, creating a robust funnel of business opportunities for its clients [2][6]
OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement